For instance, CEACAM1 may play an anticancer role in breast cancer and prostate cancer, and animal experiments have also demonstrated that breast cancer cells or prostate cancer cells overexpressing CEACAM1 have a reduced tumorigenic capacity [23–25]. Here, CEACAM1 is linked to prostate cancer.